These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 31717656)

  • 1. Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.
    Alrmali A; Saleh MHA; Kurdi SMS; Sabri H; Meghil MM; Wang HL
    Clin Exp Dent Res; 2023 Oct; 9(5):791-798. PubMed ID: 37605488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effectiveness of Advanced Platelet-Rich Fibrin in comparison with Leukocyte-Platelet-Rich Fibrin on Outcome after Dentoalveolar Surgery.
    Makki AZ; Alsulami AM; Almatrafi AS; Sindi MZ; Sembawa SN
    Int J Dent; 2021; 2021():6686857. PubMed ID: 34046064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tooth autotransplantation outcomes using platelet-rich fibrin: A promising approach; case study.
    SamavatiJame F; Alrmali A; Galindo-Fernandez P; Stuhr S; Wang HL
    Clin Adv Periodontics; 2024 May; ():. PubMed ID: 38696612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series.
    Pardo-Zamora G; Martínez Y; Moreno JA; Ortiz-Ruíz AJ
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw.
    He L; Sun X; Liu Z; Qiu Y; Niu Y
    Int J Oral Sci; 2020 Oct; 12(1):30. PubMed ID: 33087699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Leukocyte- and Platelet-Rich Fibrin to Prevent Osteonecrosis of the Jaws Associated with the Use of Bisphosphonate Therapy: A Case Series.
    Stresser FA; Parise GK; Macedo FJ; Sassi LM; Schussel JL
    J Maxillofac Oral Surg; 2023 Dec; 22(4):1159-1165. PubMed ID: 38105812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Microbiome, Oral Health and Systemic Health: A Multidirectional Link.
    Varoni EM; Rimondini L
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium Phosphate Ceramics Can Prevent Bisphosphonate-Related Osteonecrosis of the Jaw.
    Paulo S; Laranjo M; Paula A; Abrantes AM; Martins J; Marto CM; Coelho A; Casalta-Lopes J; Carvalho L; Carrilho E; Serra A; Botelho MF; Marques Ferreira M
    Materials (Basel); 2020 Apr; 13(8):. PubMed ID: 32331240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of autologous platelet rich fibrin in bone augmentation and bone regeneration at extraction socket.
    Blinstein B; Bojarskas S
    Stomatologija; 2018; 20(4):111-118. PubMed ID: 31074457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery.
    Simonpieri A; Del Corso M; Vervelle A; Jimbo R; Inchingolo F; Sammartino G; Dohan Ehrenfest DM
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1231-56. PubMed ID: 21740370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Platelet Rich Fibrin (PRF)-Based Autologous Membranes for Tooth Extraction in Patients under Bisphosphonate Therapy: A Case Report.
    Pispero A; Bancora I; Khalil A; Scarnò D; Varoni EM
    Biomedicines; 2019 Nov; 7(4):. PubMed ID: 31717656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tooth extractions in patients under antiresorptive therapy for osteoporosis: Primary closure of the extraction socket with a mucoperiosteal flap versus application of platelet-rich fibrin for the prevention of antiresorptive agent-related osteonecrosis of the jaw.
    Poxleitner P; Steybe D; Kroneberg P; Ermer MA; Yalcin-Ülker GM; Schmelzeisen R; Voss PJ
    J Craniomaxillofac Surg; 2020 Apr; 48(4):444-451. PubMed ID: 32122726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study.
    Asaka T; Ohga N; Yamazaki Y; Sato J; Satoh C; Kitagawa Y
    Clin Oral Investig; 2017 Sep; 21(7):2165-2172. PubMed ID: 27837344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report.
    Giudice A; Antonelli A; Muraca D; Fortunato L
    Indian J Dent Res; 2020; 31(5):813-818. PubMed ID: 33433526
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.